---
title: "Chemspec released its 2024 annual performance, with a net loss attributable to the parent company of 49.5316 million yuan, turning from profit to loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236429831.md"
description: "According to the Zhitong Finance APP, Chemspec released its annual report for 2024, stating that the company's operating revenue for 2024 is 675 million yuan, a year-on-year decrease of 31.11%; the net loss attributable to shareholders of the listed company is 49.5316 million yuan, turning from profit to loss; the net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, is 93.5951 million yuan, turning from profit to loss; the basic loss per share is 0.10 yuan/share"
datetime: "2025-04-17T12:51:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236429831.md)
  - [en](https://longbridge.com/en/news/236429831.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236429831.md)
---

# Chemspec released its 2024 annual performance, with a net loss attributable to the parent company of 49.5316 million yuan, turning from profit to loss

According to the Zhitong Finance APP, Chemspec (688602.SH) released its annual report for 2024, reporting an operating income of 675 million yuan for the year, a year-on-year decrease of 31.11%; a net loss attributable to shareholders of the listed company of 49.5316 million yuan, turning from profit to loss; a net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, of 93.5951 million yuan, turning from profit to loss; basic loss per share of 0.10 yuan/share

### Related Stocks

- [688602.CN](https://longbridge.com/en/quote/688602.CN.md)

## Related News & Research

- [Metallium publishes Canaccord Genuity conference presentation factsheet](https://longbridge.com/en/news/287261632.md)
- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)
- [20:38 ETHyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"](https://longbridge.com/en/news/287135394.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)
- [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md)